Perceptive Inc. published a blog exploring how PET, SPECT, MRI, and optical imaging support better-informed decisions from discovery through IND-enabling studies.

Public source

Publisher name

Public post

Every stage of early drug development brings a different question. Is the target accessible? Is the molecule reaching it? Which candidate should advance? What data are n…

Log in to read the full post

Company

Perceptive Inc.

Delivering Discovery, eClinical, and Imaging Solutions to the Global Biopharmaceutical Industry

Industry
Biotechnology Research
Location
London, GB
Company size
1,001–5,000 employees

About Perceptive Inc.

Expanding on their combined 50-year history, Perceptive provides best-in-class specialist support to global pharmaceutical, biotech, and clinical research organizations, spanning the complete R&D lifecycle, from discovery and preclinical through clinical development to post marketing. Perceptive’s offerings include imaging biomarkers and core lab services, as well as innovative technologies in randomization and trial supply management (RTSM), analytics, and software.

See more

Latest activity

19 signals

Discover more

Similar public activity from other companies.

Customize signals for your business.

Know everything happening across the B2B world, and act on the company movements that matter to you.

© 2026 SeedOpsCompany intelligence.

SeedOps.